ClearBridge LLC (Maryland)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$2.7M Sell
8,958
-62
-0.7% -$19.8K 0.82% 46
2018
Q3
$3.19M Buy
+9,020
New +$3.11M 0.78% 44
2017
Q4
Sell
-214,690
Closed -$67.2M 180
2017
Q3
$67.2M Sell
214,690
-10,950
-5% -$3.24M 1.45% 19
2017
Q2
$61.2M Sell
225,640
-1,240
-0.5% -$328K 1.3% 31
2017
Q1
$62M Sell
226,880
-48,820
-18% -$13.8M 1.34% 29
2016
Q4
$78.2M Sell
275,700
-153,470
-36% -$45.5M 1.77% 19
2016
Q3
$134M Buy
429,170
+2,300
+0.5% +$681K 2.56% 10
2016
Q2
$103M Buy
426,870
+90,840
+27% +$23.9M 2.05% 17
2016
Q1
$87.5M Buy
336,030
+98,500
+41% +$26M 1.73% 26
2015
Q4
$72.8M Buy
+237,530
New +$68.3M 1.39% 33

Other funds holding BIIB

ClearBridge LLC (Maryland)'s BIIB Position: Q4 2018 in Review

ClearBridge LLC (Maryland) reduced its Biogen (BIIB) stake by 0.69% in Q4 2018, selling an estimated $19.8K and leaving 8,958 shares worth $2.7M. The position accounts for 0.82% of the portfolio, ranked #46.

ClearBridge LLC (Maryland) first reported a position in BIIB in Q4 2015 and has held it in 10 quarters since. The position peaked at $134M in Q3 2016. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • ClearBridge LLC (Maryland) held 8,958 shares of Biogen worth $2.7M as of Q4 2018.
  • ClearBridge LLC (Maryland) sold 62 Biogen shares in Q4 2018, an estimated $19.8K.
  • Biogen made up 0.82% of ClearBridge LLC (Maryland)'s portfolio in Q4 2018, its #46 holding.
  • ClearBridge LLC (Maryland) first reported a position in Biogen in Q4 2015 and has held it in 10 quarters since.
  • ClearBridge LLC (Maryland)'s Biogen position peaked at $134M in Q3 2016.
  • 1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on ClearBridge LLC (Maryland)'s 13F filing for Q4 2018, filed 14 Feb 2019.